Literature DB >> 32312682

Emerging Mechanisms by which EMT Programs Control Stemness.

Molly M Wilson1, Robert A Weinberg2, Jacqueline A Lees1, Vincent J Guen3.   

Abstract

Tissue regeneration relies on adult stem cells (SCs) that possess the ability to self-renew and produce differentiating progeny. In an analogous manner, the development of certain cancers depends on a subset of tumor cells, called cancer stem cells (CSCs), with SC-like properties. In addition to being responsible for tumorigenesis, CSCs exhibit elevated resistance to therapy and thus drive tumor relapse post-treatment. The epithelial-mesenchymal transition (EMT) programs promote SC and CSC stemness in many epithelial tissues. Here, we provide an overview of the mechanisms underlying the relationship between stemness and EMT programs, which may represent therapeutic vulnerabilities for the treatment of cancers.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EMT; cancer stem cells; stemness

Mesh:

Substances:

Year:  2020        PMID: 32312682     DOI: 10.1016/j.trecan.2020.03.011

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  42 in total

Review 1.  RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.

Authors:  Subhadra Kumari; Santosh Kumar; Srinivasan Muthuswamy
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-07       Impact factor: 4.553

2.  RUNX2 recruits the NuRD(MTA1)/CRL4B complex to promote breast cancer progression and bone metastasis.

Authors:  Xin Yin; Xu Teng; Tianyu Ma; Tianshu Yang; Jingyao Zhang; Miaomiao Huo; Wei Liu; Yunkai Yang; Baowen Yuan; Hefen Yu; Wei Huang; Yan Wang
Journal:  Cell Death Differ       Date:  2022-05-09       Impact factor: 15.828

Review 3.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

4.  KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer.

Authors:  Mei Zhou; Prabhakar Pitta Venkata; Suryavathi Viswanadhapalli; Bridgitte Palacios; Salvador Alejo; Yihong Chen; Yi He; Uday P Pratap; Junhao Liu; Yi Zou; Zhao Lai; Takayoshi Suzuki; Andrew J Brenner; Rajeshwar R Tekmal; Ratna K Vadlamudi; Gangadhara R Sareddy
Journal:  Breast Cancer Res Treat       Date:  2020-10-14       Impact factor: 4.872

5.  Localized EMT reprograms glial progenitors to promote spinal cord repair.

Authors:  Dana Klatt Shaw; Vishnu Muraleedharan Saraswathy; Lili Zhou; Anthony R McAdow; Brooke Burris; Emily Butka; Samantha A Morris; Sabine Dietmann; Mayssa H Mokalled
Journal:  Dev Cell       Date:  2021-02-19       Impact factor: 12.270

6.  Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium.

Authors:  Lauren E Carter; David P Cook; Curtis W McCloskey; Melanie A Grondin; David A Landry; Tiffany Dang; Olga Collins; Lisa F Gamwell; Holly A Dempster; Barbara C Vanderhyden
Journal:  Commun Biol       Date:  2021-05-05

7.  Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells.

Authors:  Mara Artibani; Kenta Masuda; Zhiyuan Hu; Pascal C Rauher; Garry Mallett; Nina Wietek; Matteo Morotti; Kay Chong; Mohammad KaramiNejadRanjbar; Christos E Zois; Sunanda Dhar; Salma El-Sahhar; Leticia Campo; Sarah P Blagden; Stephen Damato; Pubudu N Pathiraja; Shibani Nicum; Fergus Gleeson; Alexandros Laios; Abdulkhaliq Alsaadi; Laura Santana Gonzalez; Takeshi Motohara; Ashwag Albukhari; Zhen Lu; Robert C Bast; Adrian L Harris; Christer S Ejsing; Robin W Klemm; Christopher Yau; Tatjana Sauka-Spengler; Ahmed Ashour Ahmed
Journal:  JCI Insight       Date:  2021-06-08

Review 8.  The roles of integrins in cancer.

Authors:  Donatella Valdembri; Guido Serini
Journal:  Fac Rev       Date:  2021-05-07

9.  Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.

Authors:  Ryne C Ramaker; Andrew A Hardigan; Emily R Gordon; Carter A Wright; Richard M Myers; Sara J Cooper
Journal:  BMC Cancer       Date:  2021-05-29       Impact factor: 4.430

10.  Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications.

Authors:  Nuria Carmona-Ule; Miriam González-Conde; Carmen Abuín; Juan F Cueva; Patricia Palacios; Rafael López-López; Clotilde Costa; Ana Belén Dávila-Ibáñez
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.